08:00 , Nov 2, 2015 |  BC Week In Review  |  Clinical News

Arno preclinical data

In human CF macrophages, Arno said AR-13 in combination with broad-spectrum antibiotics synergistically reduced antibiotic-resistant Burkholderia cenocepacia burden. In CF neutrophils, AR-13 alone significantly reduced Pseudomonas aeruginosa burden by 70%. Data were presented at the...